The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II, randomized, double-blind study of the use of rucaparib vs placebo maintenance therapy in metastatic and recurrent endometrial cancer.
 
Bradley Corr
Consulting or Advisory Role - AstraZeneca/Merck (Inst); GlaxoSmithKline (Inst); Immunogen; Imvax; Merck (Inst); Novocure (Inst)
Research Funding - Clovis Oncology (Inst)
 
Ashley Ford Haggerty
Research Funding - Clovis Oncology (Inst); GlaxoSmithKline (Inst)
 
Sarah E. Taylor
Other Relationship - AstraZeneca
 
Stefan Gysler
No Relationships to Disclose
 
Mark Aloysuis Morgan
No Relationships to Disclose
 
Kian Behbakht
No Relationships to Disclose
 
Carolyn Lefkowits
Consulting or Advisory Role - GlaxoSmithKline
 
Jill Alldredge
No Relationships to Disclose
 
Lindsay Brubaker
Consulting or Advisory Role - AstraZeneca (Inst)
 
Samantha Hopp
Research Funding - Clovis Oncology (Inst)
 
Saketh R Guntupalli
Consulting or Advisory Role - Clovis Oncology; Tesaro
Research Funding - Bristol-Myers Squibb